CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 128 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2013. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $423,000 | -12.1% | 181,411 | +7.1% | 0.00% | – |
Q4 2017 | $481,000 | -5.5% | 169,311 | -4.8% | 0.00% | – |
Q3 2017 | $509,000 | +15.9% | 177,911 | 0.0% | 0.00% | – |
Q2 2017 | $439,000 | +4.0% | 177,911 | +52.2% | 0.00% | – |
Q1 2017 | $422,000 | -11.9% | 116,911 | -13.6% | 0.00% | – |
Q4 2016 | $479,000 | -26.3% | 135,311 | -16.0% | 0.00% | -100.0% |
Q3 2016 | $650,000 | -8.1% | 161,011 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $707,000 | +4.7% | 161,011 | -9.8% | 0.00% | 0.0% |
Q1 2016 | $675,000 | -75.9% | 178,511 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $2,799,000 | +48.7% | 178,511 | 0.0% | 0.00% | 0.0% |
Q3 2015 | $1,882,000 | -58.2% | 178,511 | -0.1% | 0.00% | -50.0% |
Q2 2015 | $4,507,000 | -6.2% | 178,691 | +3.6% | 0.00% | 0.0% |
Q1 2015 | $4,807,000 | +52.7% | 172,491 | 0.0% | 0.00% | +33.3% |
Q4 2014 | $3,148,000 | +36.8% | 172,491 | -2.8% | 0.00% | +50.0% |
Q3 2014 | $2,301,000 | -23.9% | 177,541 | -4.2% | 0.00% | -33.3% |
Q2 2014 | $3,023,000 | -78.9% | 185,233 | -77.2% | 0.00% | -75.0% |
Q1 2014 | $14,357,000 | -34.7% | 812,534 | -10.6% | 0.01% | -40.0% |
Q4 2013 | $22,002,000 | -50.0% | 908,785 | -26.9% | 0.02% | -54.5% |
Q3 2013 | $44,037,000 | +101.5% | 1,242,917 | -11.2% | 0.04% | +91.3% |
Q2 2013 | $21,856,000 | – | 1,400,099 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Byrne Asset Management LLC | 86 | $2,000 | 0.00% |